MarketPeel
Insider Trading Intelligence
JG

Joana Goncalves

ORKA
CHIEF MEDICAL OFFICER · ORUKA THERAPEUTICS, INC. · CIK 0001756991
FILING MIX · LIFETIME32%/68%
BUYS
17
SELLS
36
TOTAL VALUE
$2.78M
COMPANIES
1
ACTIVE SINCE
Jan 2025
HOLDINGS NOW
40,665
AVG SELL PX
$47.89
TRADE KIND
SHOWING 53 / 53
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 44 pending
Forward-return performance of every backtestable P/S trade by Joana Goncalves, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+53.33%+3.44%+0.18%+3.26%+1.58%
14d15+26.67%+1.39%-1.06%+2.45%+2.23%
30d15+33.33%+17.97%+2.22%+15.75%+3.27%
60d15+0.00%+33.61%+4.29%+29.32%+31.81%
90d15(3 pending)+0.00%+61.23%+4.24%+56.99%+54.38%
180d15(11 pending)+0.00%+112.66%+10.25%+102.41%+102.41%
1y15(15 pending)
2y15(15 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ORKA · 40,665 shares · as of Jun 15, 2026
056,266112,532168,797225,0632026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2025
2026
2026
FLOW · 17 buys / 36 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,064$69.42$351.5K33,965Jun 15, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
947$69.69$66.0K32,718Jun 15, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500175,492Jun 15, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,636$68.38$111.9K39,029Jun 15, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
300$70.62$21.2K33,665Jun 15, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500204,063Jun 15, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$6.84$23.9K37,165Jun 15, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$7.80$27.3K40,665Jun 15, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500178,992May 15, 2026May 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$6.84$23.9K36,877May 15, 2026May 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100$63.52$6.4K33,377May 15, 2026May 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$7.80$27.3K40,377May 15, 2026May 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,100$62.42$131.1K33,477May 15, 2026May 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,800$61.56$295.5K35,577May 15, 2026May 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500207,563May 15, 2026May 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,227$65.73$277.8K36,150Apr 15, 2026Apr 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,273$66.56$151.3K33,877Apr 15, 2026Apr 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$6.84$23.9K36,877Apr 15, 2026Apr 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500182,492Apr 15, 2026Apr 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
500$67.38$33.7K33,377Apr 15, 2026Apr 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500211,063Apr 15, 2026Apr 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$7.80$27.3K40,377Apr 15, 2026Apr 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,921$40.11$117.2K38,097Mar 16, 2026Mar 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500214,563Mar 16, 2026Mar 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$7.80$27.3K41,018Mar 16, 2026Mar 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$6.84$23.9K37,518Mar 16, 2026Mar 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
641$41.30$26.5K33,377Mar 16, 2026Mar 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500185,992Mar 16, 2026Mar 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,902$41.20$119.6K35,195Mar 16, 2026Mar 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,177$41.94$49.4K34,018Mar 16, 2026Mar 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
936$32.78$30.7K34,018Feb 17, 2026Feb 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$6.84$23.9K37,518Feb 17, 2026Feb 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$7.80$27.3K41,018Feb 17, 2026Feb 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,064$32.30$195.9K34,954Feb 17, 2026Feb 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500189,492Feb 17, 2026Feb 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500218,063Feb 17, 2026Feb 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
130,000130,000Jan 23, 2026Jan 23, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
32,50034,018Jan 23, 2026Jan 23, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$6.84$23.9K5,018Jan 15, 2026Jan 16, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,619$32.24$84.4K1,518Jan 15, 2026Jan 16, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500221,563Jan 15, 2026Jan 16, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,381$31.56$138.3K4,137Jan 15, 2026Jan 16, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$7.80$27.3K8,518Jan 15, 2026Jan 16, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500192,992Jan 15, 2026Jan 16, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500196,492Dec 19, 2025Dec 19, 2025View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
641$28.53$18.3K7,877Dec 19, 2025Dec 19, 2025View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,492$30.70$45.8K4,598Dec 19, 2025Dec 19, 2025View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,500225,063Dec 19, 2025Dec 19, 2025View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,787$29.62$52.9K6,090Dec 19, 2025Dec 19, 2025View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$7.80$27.3K8,518Dec 19, 2025Dec 19, 2025View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,080$31.58$97.3K1,518Dec 19, 2025Dec 19, 2025View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,500$6.84$23.9K5,018Dec 19, 2025Dec 19, 2025View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
162,500162,500Jan 22, 2025Jan 22, 2025View →
Other insiders · ORKA
Loading peer insiders…
About this filer
CIK 0001756991
ROLE
Chief Medical Officer
PRIMARY
ORKA
COMPANIES
1
ACTIVE SINCE
Jan 2025
MARKETPEEL · /INSIDER/0001756991DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback